
Acute Lymphoblastic Leukemia (ALL) is a malignancy involving the blood and bone marrow and is characterised by the abnormal growth of immature white blood cells (lymphoblasts). The incidence peaks in children, and adults may also be diagnosed with it.
Causes
Risk Factors
The current focus of ALL treatment advancements is targeted therapy and immunotherapy. Research on CAR-T therapy has shown promising results in modifying the patient's immune cells to attack leukemia cells. Monoclonal antibodies precisely target malignant cells, and next-generation sequencing (NGS) identifies genetic mutations for personalised treatment. MRI evaluation significantly helps in treatment modification and, ultimately, outcome. Bone marrow transplant using haploidentical donors shall most definitely expand the donor pool. Novel chemotherapeutic protocols and reduced-intensity conditioning have led to improvements in survival, at least for some high-risk patients.
The medical treatment for Acute lymphoblastic leukaemia (ALL) requires evaluating the patient's severity and medical condition. The following are the treatment options:
Chemotherapy : Chemotherapy for ALL always comes first: induction chemotherapy for remission, consolidation and maintenance chemotherapy to prevent relapse and maintain the remission.
Cost Start From USD 36600 - USD 0Explore Options
Targeted Therapy : Tyrosine Kinase Inhibitors (TKIs), such as Imatinib, are used in Philadelphia chromosome-positive ALL, along with monoclonal antibodies, which target leukaemia cells and stimulate the immune response.
Cost Start From USD 10000 - USD 50000Explore Options
Stem Cell Transplantation : Allogeneic transplants from matched donors or autologous (using the patient's cells) are an option for high-risk or relapsed cases to restore normal blood cell production.
Cost Start From USD 5000 - USD 50000Explore Options
Immunotherapy : CAR-T cell therapy, a promising approach for patients with relapsed ALL, involves engineering the patient's T-cells to target and kill leukaemia cells. Immune checkpoint inhibitors are being explored to augment immune response against leukaemia.
Cost Start From USD 9000 - USD 234000Explore Options
Radiation Therapy and Supportive Care: CNS-directed radiation is indicated for leukaemias that spread to the brain, while supportive care measures, such as blood transfusions and infection prevention, can help mitigate side effects and improve the patient's outcome during treatment.
CAR-T Cell Therapy : It emerges as a revolutionised therapy for patients with Acute Lymphoblastic Leukemia (ALL), particularly for patients with minimal responses to conventional treatment.
Cost Start From USD 475000 - USD 0Explore Options
These are the standard diagnostic methods for diagnosing Acute lymphoblastic leukaemia (ALL):
Imaging Studies
Blood Tests
Bone Marrow Biopsy
Lumbar Puncture (Cerebrospinal Fluid Analysis)
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.









Singapore, Singapore
Gleneagles Hospital, located on Napier Road in Singapore, is a leading private healthcare institution offering comprehensive medical services and advanced clinical care. With 221 beds and a strong team of medical specialists, the hospital holds the Singapore Quality Class certification for excellence in healthcare. Its state-of-the-art facilities include ICU, HDU, NICU, Urgent Care Centre, operating theatres, radiology, endoscopy, laboratories, and rehabilitation units. Gleneagles specializes in orthopaedics, oncology, women’s health, and gastroenterology, offering tailored programs for cancer, bone, and gut health. With modern maternity packages and patient-friendly rooms, the hospital ensures compassionate, high-quality care focused on safety, comfort, and recovery.

Singapore, Singapore
Apart from in-detail treatment procedures available, Farrer Park Hospital located in Connexion, Singapore has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the growing reasons for Singapore being frequented for Acute Lymphoblastic Leukemia treatment:
Survival rates are likely to vary depending on the age and subtype of the disease at the time of diagnosis, as well as the response to treatment. Children diagnosed with ALL have no 5-year survival rates of about 85% to 90%. Adults have lower rates, but these rates are improving with treatment.
Yes, relapse is likely, especially for high-risk cases. Management of relapse may include aggressive chemotherapy, stem cell transplant, or CAR-T cell therapy.
Cancer treatment can be accompanied by side effects, which could include fatigue alongside nausea due to the shedding of hair, further summing it all into the incidence of infections and, sometimes, anaemia. These could be followed by adverse consequences wherein development could have taken place before birth, for instance, those possible with children or perhaps concerns with fertility among adults.
Stem cell transplants (either autologous or allogeneic) are used for high-risk or relapsed acute lymphoblastic leukaemia (ALL) patients, as they restore healthy blood cells after the patient undergoes intensive therapy, typically involving chemotherapy or radiation.
Most cases are not hereditary; however, some genetic conditions, such as Down syndrome or Li-Fraumeni syndrome, may add to the likelihood of developing ALL. A family history of leukaemia may increase the risk in moderate amounts.
Yes, CAR-T cell therapy for either relapsed or refractory ALL is available in some specialised centers.
Reputable hospitals have dedicated pediatric oncology units for treating children with acute lymphoblastic leukaemia (ALL).
There are excellent transplant centers in Singapore that offer matched and haploidentical transplants.
Depending on the staging and the protocol employed, the duration could vary from a few months to a few years.
Yes, hospitals provide long-term post-treatment follow-ups for monitoring remission and relapse.